Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CS-SKINBIOREPAIR
- Development stage
- Preclinical
- Lead developer
- DreemBio
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
CS-SKINBIOREPAIR is a phytomedicine-based dermocosmetic candidate currently in development by DreemBio. It is designed to address various skin conditions by promoting skin repair and barrier restoration. The product utilizes DreemBio's proprietary extraction technology to derive bioactive compounds from plants, aiming to provide a therapeutic effect that bridges the gap between traditional skincare and pharmaceutical dermatology. While specific molecular targets have not been disclosed, the candidate is intended for topical application to treat damaged or compromised skin and maintain skin health through natural bioactive modulation.
Beyond the preview
Go deeper on CS-SKINBIOREPAIR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CS-SKINBIOREPAIR.